Header cover image

Chinese Pharmaceuticals & Biotech Your first investment

Results

8

0 new
Based on available information up to March 12, 2025, Donald Trump’s plans for oil and gas focus on maximizing U.S. production, reducing regulatory barriers, and prioritizing fossil fuels as a cornerstone of his energy policy. Here’s a concise overview of his intentions: Boost Production and Permitting: Trump has pledged to "unleash" American oil and gas by accelerating permitting processes. On his first day in office (January 20, 2025), he signed executive orders declaring a "national energy emergency" to fast-track approvals for energy infrastructure like pipelines, refineries, and power plants. This includes expanding drilling on federal lands and offshore areas, reversing Biden-era restrictions.

8 companies

Yunnan Baiyao GroupLtd

Market Cap: CN¥89.7b

Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.

000538

CN¥50.25

7D

1.0%

1Y

-11.7%

Zhangzhou Pientzehuang Pharmaceutical

Market Cap: CN¥76.9b

Manufactures and distributes pharmaceuticals and cosmetics in China and internationally.

600436

CN¥127.40

7D

0.08%

1Y

-38.8%

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥40.7b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥24.45

7D

-0.7%

1Y

-19.3%

Beijing Tongrentang

Market Cap: CN¥33.5b

Engages in the production and sale of traditional Chinese medicine preparations in China and internationally.

600085

CN¥24.45

7D

1.6%

1Y

-33.0%

Apeloa PharmaceuticalLtd

Market Cap: CN¥23.3b

Provides raw materials various pharmaceutical factories in the People’s Republic of China and internationally.

000739

CN¥20.73

7D

-6.2%

1Y

29.6%

Tasly Pharmaceutical Group

Market Cap: CN¥22.1b

Engages in the research, development, production, and sale of pharmaceuticals in China.

600535

CN¥14.77

7D

-3.1%

1Y

-11.7%

Livzon Pharmaceutical Group

Market Cap: CN¥20.7b

Researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients (API) and intermediates in the People’s Republic of China and internationally.

000513

CN¥26.34

7D

-11.4%

1Y

-35.1%

Tonghua Dongbao Pharmaceutical

Market Cap: CN¥15.9b

Engages in the research, development, production, and sale of biological products, traditional Chinese medicines, chemical medicines, and other drugs in China and internationally.

600867

CN¥8.12

7D

-1.5%

1Y

-4.4%